Indaptus Therapeutics Inc... (INDP)
NASDAQ: INDP
· Real-Time Price · USD
7.58
-0.23 (-2.94%)
At close: Aug 15, 2025, 3:59 PM
7.30
-3.69%
After-hours: Aug 15, 2025, 05:43 PM EDT
Indaptus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 1.47K | n/a | n/a | n/a | 1.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 735.00 | 320.00 | 321.00 | 322.00 | 321.00 | 321.00 | 392.00 | 534.00 | 534.00 | 535.00 | n/a | 7.38M | 4.18M |
Gross Profit | n/a | n/a | 735.00 | n/a | n/a | -735 | 1.61K | -321 | -322 | -321 | -321 | -392 | -534 | -534 | -535 | n/a | -7.38M | -4.18M |
Operating Income | -4.46M | -4.57M | -4.17M | -3.14M | -4.11M | -3.94M | -4.18M | -4.25M | -3.5M | -4.46M | -4.09M | -3.55M | -3.87M | -3.4M | -3.22M | -3.37M | -7.38M | -613.98K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 827.00 | n/a | n/a |
Pretax Income | -5.23M | -4.53M | -4.13M | -3.07M | -4.02M | -3.81M | -4M | -3.92M | -3.25M | -4.25M | -3.66M | -3.47M | -3.84M | -3.37M | -3.22M | -3.37M | -7.42M | -612.42K |
Net Income | -5.23M | -4.53M | -4.13M | -3.07M | -4.02M | -3.81M | -4M | -3.92M | -3.25M | -4.05M | -3.22M | -3.38M | -3.84M | -3.33M | -3.22M | -3.37M | -7.43M | -612.42K |
Selling & General & Admin | 2.29M | 1.76M | 1.69M | 1.68M | 2.39M | 2.35M | 2.15M | 2.02M | 2.01M | 2.58M | 2.18M | 1.94M | 2.36M | 2.1M | 2.27M | 2.67M | 2.39M | 124.25K |
Research & Development | 2.17M | 2.81M | 2.48M | 1.47M | 1.71M | 1.59M | 2.03M | 2.23M | 1.48M | 1.88M | 1.91M | 1.61M | 1.51M | 1.3M | 944.64K | 697.67K | 1.81M | 489.72K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -638 | n/a | n/a | n/a | n/a | n/a | n/a | 33.76K | n/a | n/a | 827.00 | n/a | 1.55K |
Operating Expenses | 4.46M | 4.57M | 4.17M | 3.14M | 4.11M | 3.94M | 4.18M | 4.25M | 3.5M | 4.46M | 4.09M | 3.55M | 3.87M | 3.4M | 3.22M | 3.37M | 4.19M | 613.98K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 201.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.46M | 4.57M | 4.17M | 3.14M | 4.11M | 3.94M | 4.18M | 4.25M | 3.5M | 4.46M | 4.09M | 3.55M | 3.87M | 3.4M | 3.22M | 3.37M | 4.19M | 613.98K |
Income Tax Expense | n/a | n/a | -4 | n/a | n/a | n/a | n/a | n/a | n/a | -201.93K | -431.25K | -86.18K | n/a | -36.92K | -13K | n/a | 13K | n/a |
Shares Outstanding (Basic) | 574.92K | 9.36M | 9.36M | 9.51M | 8.54M | 8.44M | 8.4M | 8.4M | 8.4M | 8.4M | 8.27M | 8.26M | 8.26M | 8.26M | 4.09M | 4.18M | 5.41M | 5.41M |
Shares Outstanding (Diluted) | 574.92K | 9.36M | 9.36M | 9.51M | 8.54M | 8.44M | 8.4M | 8.4M | 8.4M | 8.4M | 8.27M | 8.26M | 8.26M | 8.26M | 4.09M | 4.18M | 5.41M | 5.41M |
EPS (Basic) | -9.1 | -0.48 | -0.38 | -0.32 | -0.47 | -0.45 | -0.48 | -0.47 | -0.39 | -0.48 | -0.39 | -0.41 | -0.46 | -0.4 | -0.8 | -0.81 | -1.37 | -0.11 |
EPS (Diluted) | -9.1 | -0.48 | -0.38 | -0.32 | -0.47 | -0.45 | -0.48 | -0.47 | -0.39 | -0.48 | -0.39 | -0.41 | -0.46 | -0.4 | -0.8 | -0.81 | -1.37 | -0.11 |
EBITDA | -5.23M | -4.57M | -4.17M | -3.14M | -4.11M | -3.94M | -4.18M | -4.25M | -3.49M | -4.45M | -4.09M | -3.55M | -3.87M | -3.4M | -3.22M | -3.37M | -528.43K | -613.76K |
EBIT | -5.23M | -4.57M | -4.17M | -3.14M | -4.11M | -3.94M | -4.18M | -4.25M | -3.5M | -4.46M | -4.09M | -3.55M | -3.87M | -3.4M | -3.22M | -3.37M | -528.64K | -613.98K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 735.00 | 320.00 | 321.00 | 322.00 | 321.00 | 321.00 | 392.00 | 534.00 | 534.00 | 535.00 | -1.18M | 652K | 526K |